Cargando…

Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis

BACKGROUND: A subset of familial forms of amyotrophic lateral sclerosis (ALS) are caused by mutations in the gene coding Cu/Zn-superoxide dismutase (SOD1). Mutant SOD1 proteins are susceptible to misfolding and abnormally accumulated in spinal cord, which is most severely affected in ALS. It, howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokuda, Eiichi, Takei, Yo-ichi, Ohara, Shinji, Fujiwara, Noriko, Hozumi, Isao, Furukawa, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862823/
https://www.ncbi.nlm.nih.gov/pubmed/31744522
http://dx.doi.org/10.1186/s13024-019-0341-5
_version_ 1783471640517017600
author Tokuda, Eiichi
Takei, Yo-ichi
Ohara, Shinji
Fujiwara, Noriko
Hozumi, Isao
Furukawa, Yoshiaki
author_facet Tokuda, Eiichi
Takei, Yo-ichi
Ohara, Shinji
Fujiwara, Noriko
Hozumi, Isao
Furukawa, Yoshiaki
author_sort Tokuda, Eiichi
collection PubMed
description BACKGROUND: A subset of familial forms of amyotrophic lateral sclerosis (ALS) are caused by mutations in the gene coding Cu/Zn-superoxide dismutase (SOD1). Mutant SOD1 proteins are susceptible to misfolding and abnormally accumulated in spinal cord, which is most severely affected in ALS. It, however, remains quite controversial whether misfolding of wild-type SOD1 is involved in more prevalent sporadic ALS (sALS) cases without SOD1 mutations. METHODS: Cerebrospinal fluid (CSF) from patients including sALS as well as several other neurodegenerative diseases and non-neurodegenerative diseases was examined with an immunoprecipitation assay and a sandwich ELISA using antibodies specifically recognizing misfolded SOD1. RESULTS: We found that wild-type SOD1 was misfolded in CSF from all sALS cases examined in this study. The misfolded SOD1 was also detected in CSF from a subset of Parkinson’s disease and progressive supranuclear palsy, albeit with smaller amounts than those in sALS. Furthermore, the CSF samples containing the misfolded SOD1 exhibited significant toxicity toward motor neuron-like NSC-34 cells, which was ameliorated by removal of the misfolded wild-type SOD1 with immunoprecipitation. CONCLUSIONS: Taken together, we propose that misfolding of wild-type SOD1 in CSF is a common pathological process of ALS cases regardless of SOD1 mutations.
format Online
Article
Text
id pubmed-6862823
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68628232019-12-11 Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis Tokuda, Eiichi Takei, Yo-ichi Ohara, Shinji Fujiwara, Noriko Hozumi, Isao Furukawa, Yoshiaki Mol Neurodegener Research Article BACKGROUND: A subset of familial forms of amyotrophic lateral sclerosis (ALS) are caused by mutations in the gene coding Cu/Zn-superoxide dismutase (SOD1). Mutant SOD1 proteins are susceptible to misfolding and abnormally accumulated in spinal cord, which is most severely affected in ALS. It, however, remains quite controversial whether misfolding of wild-type SOD1 is involved in more prevalent sporadic ALS (sALS) cases without SOD1 mutations. METHODS: Cerebrospinal fluid (CSF) from patients including sALS as well as several other neurodegenerative diseases and non-neurodegenerative diseases was examined with an immunoprecipitation assay and a sandwich ELISA using antibodies specifically recognizing misfolded SOD1. RESULTS: We found that wild-type SOD1 was misfolded in CSF from all sALS cases examined in this study. The misfolded SOD1 was also detected in CSF from a subset of Parkinson’s disease and progressive supranuclear palsy, albeit with smaller amounts than those in sALS. Furthermore, the CSF samples containing the misfolded SOD1 exhibited significant toxicity toward motor neuron-like NSC-34 cells, which was ameliorated by removal of the misfolded wild-type SOD1 with immunoprecipitation. CONCLUSIONS: Taken together, we propose that misfolding of wild-type SOD1 in CSF is a common pathological process of ALS cases regardless of SOD1 mutations. BioMed Central 2019-11-19 /pmc/articles/PMC6862823/ /pubmed/31744522 http://dx.doi.org/10.1186/s13024-019-0341-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tokuda, Eiichi
Takei, Yo-ichi
Ohara, Shinji
Fujiwara, Noriko
Hozumi, Isao
Furukawa, Yoshiaki
Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
title Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
title_full Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
title_fullStr Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
title_full_unstemmed Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
title_short Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
title_sort wild-type cu/zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862823/
https://www.ncbi.nlm.nih.gov/pubmed/31744522
http://dx.doi.org/10.1186/s13024-019-0341-5
work_keys_str_mv AT tokudaeiichi wildtypecuznsuperoxidedismutaseismisfoldedincerebrospinalfluidofsporadicamyotrophiclateralsclerosis
AT takeiyoichi wildtypecuznsuperoxidedismutaseismisfoldedincerebrospinalfluidofsporadicamyotrophiclateralsclerosis
AT oharashinji wildtypecuznsuperoxidedismutaseismisfoldedincerebrospinalfluidofsporadicamyotrophiclateralsclerosis
AT fujiwaranoriko wildtypecuznsuperoxidedismutaseismisfoldedincerebrospinalfluidofsporadicamyotrophiclateralsclerosis
AT hozumiisao wildtypecuznsuperoxidedismutaseismisfoldedincerebrospinalfluidofsporadicamyotrophiclateralsclerosis
AT furukawayoshiaki wildtypecuznsuperoxidedismutaseismisfoldedincerebrospinalfluidofsporadicamyotrophiclateralsclerosis